Bleeding Patterns and Management in IUD Users

Understanding Normal Bleeding Patterns with IUDs

The Centers for Disease Control and Prevention recommends that bleeding patterns vary depending on the type of IUD, with copper IUDs causing unscheduled spotting, light bleeding, heavy or prolonged bleeding during the first 3-6 months, and generally decreasing over time 1
The Centers for Disease Control and Prevention notes that levonorgestrel IUDs (LNG-IUDs) are expected to cause unscheduled spotting or light bleeding during the first 3-6 months, with bleeding generally decreasing over time, and many women eventually experiencing only light menstrual bleeding or amenorrhea 2
Heavy or prolonged bleeding is uncommon with LNG-IUDs but more common with copper IUDs, according to the Centers for Disease Control and Prevention 2, 1

The Centers for Disease Control and Prevention suggests checking for IUD displacement, which can cause abnormal bleeding, when a woman with an IUD who previously had no bleeding develops bleeding 2
The Centers for Disease Control and Prevention recommends evaluating for sexually transmitted infections or pelvic inflammatory disease when new-onset bleeding occurs 2
The Centers for Disease Control and Prevention advises ruling out pregnancy, especially if the bleeding pattern has changed abruptly, when a woman with an IUD experiences new-onset bleeding 2
The Centers for Disease Control and Prevention recommends assessing for new pathologic uterine conditions such as polyps or fibroids when new-onset bleeding occurs 2
The Centers for Disease Control and Prevention suggests verifying proper IUD placement by checking for the presence of strings when new-onset bleeding occurs 3

For copper IUD users with heavy or prolonged bleeding, the Centers for Disease Control and Prevention recommends NSAIDs for short-term treatment (5-7 days) as a potentially effective option 1
The Centers for Disease Control and Prevention notes that tranexamic acid may reduce blood loss in copper IUD users with heavy or prolonged bleeding, though safety concerns exist regarding thrombosis risk 1
The Centers for Disease Control and Prevention states that no specific medical treatments are recommended in guidelines for LNG-IUD users with irregular bleeding 2
The Centers for Disease Control and Prevention advises providing reassurance that bleeding irregularities are generally not harmful for LNG-IUD users 2
If bleeding persists and is unacceptable to the patient, the Centers for Disease Control and Prevention recommends counseling on alternative contraceptive methods 2, 1

The Centers for Disease Control and Prevention recommends not automatically attributing new bleeding to medications like prednisone without first investigating potential underlying causes 2, 1
The Centers for Disease Control and Prevention notes that continuation rates with IUDs are improved when patients receive proper counseling about expected bleeding patterns 2, 1
Approximately half of LNG-IUD users experience amenorrhea or oligomenorrhea by 2 years of use, according to the Centers for Disease Control and Prevention 2

The Centers for Disease Control and Prevention recommends excluding underlying pathology, including pregnancy, sexually transmitted infections, and new pathologic uterine conditions, before initiating treatment for bleeding in IUD users 4
NSAIDs, such as mefenamic acid 500 mg three times daily for 5 days, have demonstrated statistically significant reductions in mean menstrual blood loss in copper IUD users, and are recommended as first-line treatment 4
Tranexamic acid 3.9 grams daily for 5 days can be used as second-line treatment if NSAIDs fail or are contraindicated, and has shown significant reduction in mean blood loss among copper IUD users with heavy bleeding 4
The American College of Obstetricians and Gynecologists recommends considering IUD removal if bleeding persists despite medical management, severely impacts quality of life, or is unacceptable to the patient after appropriate treatment trials 4, 5

Norethisterone is not FDA-approved for contraception and has documented association with increased thrombosis risk, particularly in patients with underlying risk factors, and is not recommended as standard treatment for IUD-associated bleeding 4, 6
Combined oral contraceptives can be used as third-line treatment for IUD-associated bleeding, but only for patients without contraindications to estrogen 4

The type of IUD used can impact bleeding patterns, with copper IUDs more commonly associated with heavy or prolonged bleeding, and levonorgestrel IUDs more commonly associated with spotting or light bleeding 4
Approximately 50% of levonorgestrel IUD users achieve amenorrhea by 2 years, and unscheduled spotting or light bleeding during the first 3-6 months of use is expected and generally not harmful 4

In women using a Mirena IUD who experience persistent or unacceptable bleeding after the initial adjustment period, clinicians should provide counseling about alternative contraceptive options and, if desired, offer a different method to maintain effective birth control. 7

For Mirena‑associated bleeding, NSAIDs (e.g., ibuprofen) and tranexamic acid should not be prescribed, as these agents are recommended only for heavy bleeding associated with copper IUDs and have not been shown to be effective for levonorgestrel IUD‑related bleeding. [7][8]